Autologous tumor cell vaccination combined with systemic CpG-B and IFN- α promotes immune activation and induces clinical responses in patients with metastatic renal cell carcinoma: a phase II trial
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Cancer Vaccines | Carcinoma | Immunotherapy | Kidney Cancer | Renal Cell Carcinoma | Vaccines